PF-07985045: Clinical Trials

1 trial of PF-07985045, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow PF-07985045: new trials by email Literature Review of PF-07985045 trials Research Report on PF-07985045

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
PF-07985045, Gemcitabine, Nab-paclitaxel - Carcinoma, Pancreatic Ductal, Colorectal Neoplasms
Phase 1TerminatedPfizer302024-12-102026-05-22

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Pancreatic Ductal (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Pfizer (1)

Countries

Puerto Rico (1)  ·  United States (1)